Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

ABUSABUS
27 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ARBUTUS BIOPHARMA CORP

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 1.4M shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $6.9M as of 2026-Q2. The position was increased (+2.1% shares). ABUS represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$6.9M

Current Shares

1.4M

Total Value Change

+$6.6M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+2.1%
$6.9M0.0%$4.80
28
2026-Q1
Decreased
1.4M
-10.3%
$6.3M0.0%$4.69
0
2025-Q4
Increased
1.6M
+22.6%
$7.5M0.0%$4.62
33
2025-Q3
Increased
1.3M
+1.7%
$5.8M0.0%$4.46
28
2025-Q2
Increased
1.3M
+2.6%
$3.9M0.0%$3.13
27
2025-Q1
Decreased
1.2M
-0.0%
$4.3M0.0%$3.50
0
2024-Q4
Increased
1.2M
+0.8%
$4M0.0%$3.20
27
2024-Q3
Increased
1.2M
+218.5%
$4.7M0.0%$3.83
43
2024-Q2
Increased
380,583
+12.2%
$1.2M0.0%$3.09
28
2024-Q1
Decreased
339,215
-2.9%
$875,1750.0%$2.58
0
2023-Q4
Unchanged
349,358
0.0%
$873,3950.0%$2.50
0
2023-Q3
Increased
349,358
+4.0%
$709,1970.0%$2.03
26
2023-Q2
Increased
336,073
+8.8%
$772,9680.0%$2.24
27
2023-Q1
Increased
308,969
+1.2%
$936,1760.0%$3.02
25
2022-Q4
Increased
305,280
+6.2%
$711,3020.0%$2.33
26
2022-Q3
Decreased
287,419
-0.2%
$549,0000.0%$1.98
0
2022-Q2
Increased
287,954
+20.1%
$781,0000.0%$2.70
29
2022-Q1
Increased
239,713
+14.5%
$715,0000.0%$2.98
28
2021-Q4
Unchanged
209,375
0.0%
$815,0000.0%$3.88
0
2021-Q3
Increased
209,375
+12.3%
$899,0000.0%$4.27
28
2021-Q2
Increased
186,468
+791.7%
$565,0000.0%$3.15
39
2021-Q1
Unchanged
20,912
0.0%
$70,0000.0%$3.15
0
2020-Q4
Decreased
20,912
-36.5%
$75,0000.0%$3.72
0
2020-Q3
New
32,912
-
$104,0000.0%$3.18
33
2019-Q2
Exited
0
-100.0%
$00.0%$2.08
0
2019-Q1
Unchanged
65,900
0.0%
$236,0000.0%$3.58
0
2018-Q4
New
65,900
-
$253,0000.0%$3.88
32

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used